Friday, December 19, 2025 | 09:44 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

US inks $1.5 bn deal with Moderna for 100 mn doses of Covid-19 'vaccine'

The US government previously gave Moderna around $1 billion to fund its research efforts, bringing total US funding to around $2.5 billion

Coronavirus, vaccine, covid, drugs, Sepsivac, clinical trials
premium

Moderna's price per dose comes to around $30.50 per person for a two dose regimen

Jeff Mason and Carl O'Donnell | Reuters
The United States has entered an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential Covid-19 vaccine for around $1.5 billion (£1.15 billion), the company and White House said on Tuesday.

The United States in recent weeks has made deals to acquire hundreds of millions of doses of potential Covid-19 vaccines from several companies as part of its Operation Warp Speed program, which aims to deliver a vaccine in the country by the end of the year.

Moderna's price per dose comes to around $30.50 per person for a two dose regimen.

With the exception of